Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study
在首批病毒学抑制的 HIV 感染青少年队列中，长效注射卡博特韦或利匹韦林的可接受性和耐受性（IMPAACT 2017/MOCHA）：一项 1/2 期、多中心、开放标签、非对照剂量探索研究的二次分析
期刊:Lancet HIV
影响因子:
doi:10.1016/S2352-3018(23)00301-6
Lowenthal, Elizabeth D; Chapman, Jennifer; Ohrenschall, Rachel; Calabrese, Katherine; Baltrusaitis, Kristin; Heckman, Barbara; Yin, Dwight E; Agwu, Allison L; Harrington, Conn; Van Solingen-Ristea, Rodica M; McCoig, Cynthia C; Adeyeye, Adeola; Kneebone, Jared; Chounta, Vasiliki; Smith-Anderson, Christiana; Camacho-Gonzalez, Andres; D'Angelo, Jessica; Bearden, Allison; Crauwels, Herta; Huang, Jenny; Buisson, Sarah; Milligan, Ryan; Ward, Shawn; Bolton-Moore, Carolyn; Gaur, Aditya H
